Staphylococcus aureus is one of the most important human pathogens worldwide. Its high
antibiotic resistance profile reinforces the need for new interventions like vaccines in …

Staphylococcus aureus infections are associated with an enormous burden of morbidity,
mortality and increase of patient hospital length of stay and costs. S. aureus is impressively …

No licensed Staphylococcus aureus (S. aureus) vaccine is currently available. To develop
an effective S. aureus vaccine, we selected the recombinant proteins staphylococcal …

Integrated Biotherapeutic (IBT) was founded by Dr. M. Javad Aman as a multi-program, multi-
platform company focused on discovering and developing vaccines and …

Staphylococcus aureus, a gram-positive opportunistic pathogen, has become a growing
health concern because of its ability to cause a myriad of infections in both hospital and …

Staphylococcus aureus bloodstream infection can have potentially catastrophic
consequences for patients on hemodialysis. Consequently, an effective vaccine to prevent S …

Staphylococcus aureus is a Gram-positive bacterium that can persist in nature under hostile
environmental conditions and interacts with humans as both commensal and pathogen. It is …

Antibiotic resistance has become a global health problem requiring urgent intervention. The
pace of development and frequency of transmission of antimicrobial resistance have …

Staphylococcus aureus is a leading cause of significant morbidity and mortality and an
enormous economic burden to public health worldwide. Infections caused by …

The development and use of antibacterial glycoconjugate vaccines have significantly
reduced the occurrence of potentially fatal childhood and adult diseases such as …